Bolar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.42 M
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.59 M
About Bolar Pharmaceuticals
Bolar Pharmaceuticals Pvt Ltd. (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 May 1989 and has a history of 35 years and eight months. Its registered office is in Na, Jharkhand.
The Company is engaged in the Real Estate Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.42 M.
The company has closed loans amounting to ₹3.59 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pratik Ajmera and Pradeep Jain serve as directors at the Company.
Company Details
- LocationNa, Jharkhand
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U00304JH1989PTC003431
- Company No.
003431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Bolar Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratik Ajmera  | Director | 30-Jun-2014 | Current |
| Pradeep Jain | Director | 25-May-1989 | Current |
Financial Performance of Bolar Pharmaceuticals.
Bolar Pharmaceuticals Pvt Ltd., for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bolar Pharmaceuticals?
In 2017, Bolar Pharmaceuticals had a promoter holding of 14.60% and a public holding of 85.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹3.59 M
Charges Breakdown by Lending Institutions
- Bihar State Financial Corporation : 0.36 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 1989 | Bihar State Financial Corporation | ₹3.59 M | Satisfied |
How Many Employees Work at Bolar Pharmaceuticals?
Unlock and access historical data on people associated with Bolar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bolar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bolar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
